ALCRESTA THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
ALCRESTA THERAPEUTICS, INC. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include ILIPASE, ALCRESTA, RELIZORB, and ALCRESTA THERAPEUTICS. The owner is based in NEWTON, MA.
ONE NEWTON EXECUTIVE PARK, SUITE 100
NEWTON, MA 02462
Showing of trademarks Trademarks
Trademark Classifications
ALCRESTA THERAPEUTICS, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does ALCRESTA THERAPEUTICS, INC. have?
ALCRESTA THERAPEUTICS, INC. has 11 U.S. trademarks filed with the USPTO. Of these, 5 registered, 6 abandoned.
What trademark classes does ALCRESTA THERAPEUTICS, INC. file in?
ALCRESTA THERAPEUTICS, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 11 (Environmental Control). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ALCRESTA THERAPEUTICS, INC.'s most well-known trademarks?
ALCRESTA THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as ILIPASE, ALCRESTA, RELIZORB, and ALCRESTA THERAPEUTICS. These are among 5 currently registered trademarks in the portfolio.
What is ALCRESTA THERAPEUTICS, INC.'s trademark registration success rate?
ALCRESTA THERAPEUTICS, INC. has a 45% trademark registration rate, with 5 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.